The GMZ2 malaria vaccine: from concept to efficacy in humans

• Egile Nagusiak: Michael Theisen (Egilea), Bright Adu (Egilea), Benjamin Mordmüller (Egilea), Subhash Singh (Egilea)
• Formatua: Liburua
• Argitaratua: Taylor & Francis Group, 2017-09-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Introduction: GMZ2 is a recombinant protein consisting of conserved domains of GLURP and MSP3, two asexual blood-stage antigens of Plasmodium falciparum, and is designed with the aim of mimicking naturally acquired anti-malarial immunity. The rationale for combining these two antigens is based on a...